Latest Strategy News

Page 379 of 920
Cluey Ltd reported a 50% improvement in EBITDA and its first positive operating cash flow quarter in FY25, driven by cost efficiencies and a return to student growth. The company is now pivoting towards AI-enabled product innovation to fuel sustainable expansion.
Victor Sage
Victor Sage
29 Aug 2025
Jupiter Mines has declared a final unfranked dividend of 0.75 cents per share for H2 FY2025, reflecting a solid payout ratio amid fluctuating earnings and Tshipi dividend receipts.
Maxwell Dee
Maxwell Dee
29 Aug 2025
Acrux Ltd reported a 44% revenue decline and a modest increase in net loss for FY25, while expanding its US topical generics portfolio and entering the Saudi Arabian market. The company signals a strategic pivot amid intensifying competition and lower returns.
Victor Sage
Victor Sage
29 Aug 2025
Cluey Ltd has marked a pivotal year with a $4.4 million EBITDA improvement and its first positive operating cash flow quarter, alongside renewed student growth. The company is now pivoting towards AI-driven product expansion to sustain momentum.
Victor Sage
Victor Sage
29 Aug 2025
Australian Dairy Nutritionals Group (ASX, AHF) reported a 14% revenue increase to $7.17 million for FY25, driven by a nearly fourfold surge in its infant formula segment, while reducing its net loss by 29%. The company remains debt-free and is expanding its footprint in China and Vietnam.
Victor Sage
Victor Sage
29 Aug 2025
Next Science Limited reported a 7% revenue decline and a 20% reduction in net loss for H1 2025, alongside a major $50 million asset sale agreement with OSARTIS GmbH. The transaction, approved by shareholders, signals a strategic pivot for the biofilm-focused medical device company.
Ada Torres
Ada Torres
29 Aug 2025
AF Legal Group has reported a strong FY25 with 27% revenue growth and a 77% increase in normalised profit, driven by strategic acquisitions and operational improvements.
Victor Sage
Victor Sage
29 Aug 2025
Boss Energy reports a strong financial foundation with positive operating cash flow and a robust balance sheet in FY2025, its first full year of uranium production. Despite a net loss driven by non-cash costs, the company positions itself for growth amid rising uranium prices.
Maxwell Dee
Maxwell Dee
29 Aug 2025
LTR Pharma Limited (ASX, LTP) reported significant progress in FY25, advancing its novel intranasal treatments for erectile dysfunction and expanding its commercial footprint in Australia and the US. The company secured key partnerships and capital raises, positioning itself for regulatory milestones and global market entry.
Ada Torres
Ada Torres
29 Aug 2025
Savannah Goldfields Limited is poised to restart gold production in 2025 at its Georgetown and Agate Creek sites, backed by solid ore reserves and ambitious exploration plans to extend mine life.
Maxwell Dee
Maxwell Dee
29 Aug 2025
dusk Group Limited reported solid FY25 results with sales up 8.7% and EBIT rising 22.9%, driven by strong online growth and disciplined cost control. The company signals cautious optimism for FY26 amid product relaunches and store format trials.
Logan Eniac
Logan Eniac
29 Aug 2025
Gratifii Limited has reported a robust FY25 with revenue and transaction values more than doubling, driven by key acquisitions and new product launches. The company is poised for further growth in FY26 with platform upgrades and expanding client partnerships.
Sophie Babbage
Sophie Babbage
29 Aug 2025